
ESCRS 2023 Vienna: Monday
Monday, September 11th, 2023, at the ESCRS conference in Vienna, saw ELZA’s surgerons and researchers provide attendees with a series of presentations centered around advancements

Monday, September 11th, 2023, at the ESCRS conference in Vienna, saw ELZA’s surgerons and researchers provide attendees with a series of presentations centered around advancements

Sunday, September 10th, 2023, continued the trend of informative presentations at the ESCRS 2023 conference in Vienna. Here’s a straightforward rundown of the day’s events:

The European Society of Cataract and Refractive Surgeons (ESCRS) 2023 conference unfolded at Vienna’s Messe Wien, Austria. Today, September 8th, 2023, was marked by a

Join us at #ESCRS2023 in Vienna! ELZA’s top surgeons & researchers will present the latest in ophthalmic treatments. Dive deep into innovation with us! ????????️ #ELZA at #ESCRS

Switzerland, particularly Zurich, has been a leader in corneal cross-linking (CXL) research and innovation for over two decades, explained ELZA’s Medical Director, Prof. Farhad Hafezi,

DGII aktuell features ELZA Medical Director Prof. Farhad Hafezi on modern corneal cross-linking strategies.

CRST explores how artificial intelligence is improving ophthalmic diagnostics, with insights from ELZA’s Prof. Farhad Hafezi.

Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News (OSN), where he spoke about advancing CXL technology for the treatment of corneal ectasias like keratoconus. The interview covered three main topics.

Léonard Kollros is the lead Optometrist at the ELZA Institute, and this month, a paper he authored was published in the Journal Français d’Ophtalmologie. It

The 18th CXL Experts’ Meeting, led by ELZA’s CMO, Prof. Farhad Hafezi, was held last weekend in Zurich, Switzerland.
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.